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Toxicology, Medical College of Georgia, Augusta University and Charlie Norwood VA Medical Center, Augusta, GA, USA; dMedical Research Council
Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, Scotland, UK; eDivision of Cardiology, Departments of Internal
Medicine and Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA; fDepartment of Pathology and Laboratory
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ABSTRACT
Ischemic preconditioning (IPC) affords tissue protection in organs including kidneys; however, the
underlying mechanism remains unclear. Here we demonstrate an important role of macroautophagy/
autophagy (especially mitophagy) in the protective effect of IPC in kidneys. IPC induced autophagy in
renal tubular cells in mice and suppressed subsequent renal ischemia-reperfusion injury (IRI). The
protective effect of IPC was abolished by pharmacological inhibitors of autophagy and by the ablation
of Atg7 from kidney proximal tubules. Pretreatment with BECN1/Beclin1 peptide induced autophagy and
protected against IRI. These results suggest the dependence of IPC protection on renal autophagy.
During IPC, the mitophagy regulator PINK1 (PTEN induced putative kinase 1) was activated. Both IPC and
BECN1 peptide enhanced mitolysosome formation during renal IRI in mitophagy reporter mice, suggest-
ing that IPC may protect kidneys by activating mitophagy. We further established an in vitro model of
IPC by inducing ‘chemical ischemia’ in kidney proximal tubular cells with carbonyl cyanide 3-chlorophe-
nylhydrazone (CCCP). Brief treatment with CCCP protected against subsequent injury in these cells and
the protective effect was abrogated by autophagy inhibition. In vitro IPC increased mitophagosome
formation, enhanced the delivery of mitophagosomes to lysosomes, and promoted the clearance of
damaged mitochondria during subsequent CCCP treatment. IPC also suppressed mitochondrial depolar-
ization, improved ATP production, and inhibited the generation of reactive oxygen species. Knockdown
of Pink1 suppressed mitophagy and reduced the cytoprotective effect of IPC. Together, these results
suggest that autophagy, especially mitophagy, plays an important role in the protective effect of IPC.
Abbreviations: ACTB: actin, beta; ATG: autophagy related; BNIP3: BCL2 interacting protein 3; BNIP3L/
NIX: BCL2 interacting protein 3 like; BUN: blood urea nitrogen; CASP3: caspase 3; CCCP: carbonyl cyanide
3-chlorophenylhydrazone; COX4I1: cytochrome c oxidase subunit 4I1; COX8: cytochrome c oxidase
subunit 8; DAPI: 4ʹ,6-diamidino-2-phenylindole; DNM1L: dynamin 1 like; EGFP: enhanced green fluor-
escent protein; EM: electron microscopy; ER: endoplasmic reticulum; FC: floxed control; FIS1: fission,
mitochondrial 1; FUNDC1: FUN14 domain containing 1; H-E: hematoxylin-eosin; HIF1A: hypoxia inducible
factor 1 subunit alpha; HSPD1: heat shock protein family D (Hsp60) member 1; IMMT/MIC60: inner
membrane mitochondrial protein; IPC: ischemic preconditioning; I-R: ischemia-reperfusion; IRI: ischemia-
reperfusion injury; JC-1: 5,5ʹ,6,6ʹ-tetrachloro-1,1ʹ,3,3ʹ-tetraethylbenzimidazolylcarbocyanine iodide; KO:
knockout; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; mito-QC: mito-quality
control; mRFP: monomeric red fluorescent protein; NAC: N-acetylcysteine; PINK1: PTEN induced putative
kinase 1; PPIB: peptidylprolyl isomerase B; PRKN: parkin RBR E3 ubiquitin protein ligase; ROS: reactive
oxygen species; RPTC: rat proximal tubular cells; SD: standard deviation; sIPC: simulated IPC; SQSTM1/
p62: sequestosome 1; TOMM20: translocase of outer mitochondrial membrane 20; TUNEL: terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling
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Introduction
Ischemic preconditioning (IPC) consists of a short period of
non-lethal ischemia-reperfusion (I-R), which is one of the
most effective interventions known to protect the heart,
brain, kidney, liver, and other organs from subsequent severe
ischemia-reperfusion injury (IRI) [1,2]. From studies in myo-
cardium, two windows of protection are characterized in IPC:
an early effect termed classical or acute IPC and a late phase
of resistance known as second window of protection or
delayed IPC. Acute IPC occurs immediately following the
preconditioning stimulus and lasts for 2 to 3 h. Delayed IPC
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reappears a day later and lasts for a few days [1]. In the
kidney, IPC has been shown to reduce acute kidney injury
induced by renal I-R in many animal species [3–5]. Renal IPC
is also effective in both the early and late phases of precondi-
tioning [6]. As an endogenous defense mechanism, IPC
induces a number of adaptive changes in the preconditioned
tissues, including altered energy metabolism, better electrolyte
and acid-base homeostasis, less production of oxygen free
radicals, reduced inflammatory responses and apoptosis, and
improved microcirculatory perfusion. All of these changes
contribute to the tolerance of the preconditioned tissues to
sustained ischemia and following reperfusion [2].
Autophagy is an adaptive response activated upon stress to
maintain cellular energy homeostasis and to remove protein
aggregates and damaged organelles via the autolysosomal
degradation pathway [7,8]. Growing evidence has suggested
the involvement of autophagy in IPC protection in the heart,
brain and liver. IPC induces autophagy in myocardium of
mice and in isolated rat hearts, which is essential for the
cardioprotection afforded by IPC [9,10]. In rat brains, autop-
hagy is activated by focal cerebral IPC and protects against
brain damage induced by subsequent permanent focal ische-
mia [11–14]. In addition, IPC in livers protects against IRI via
autophagy mediated by heme oxygenase-1 or nitric oxide
[15,16]. Despite these findings, whether autophagy contri-
butes to the protection of IPC in kidneys has not been
reported. Moreover, it remains unclear how autophagy in
IPC protects against subsequent tissue damage.
Maintaining a healthy mitochondrial network is critical for
cell survival, as accumulation of damaged mitochondria pro-
duces reactive oxygen species (ROS) and also releases cell
death factors. The selective clearance of damaged mitochondria
by autophagy is termed mitophagy, which serves an endpoint of
mitochondrial quality control [17–19]. Mitophagy initiation
requires: (1) mitochondrial fragmentation to produce size-
suitable mitochondria for autophagic sequestration; (2) priming
of the dysfunctional mitochondria for autophagy recognition;
(3) induction of general autophagymachinery to incorporate the
primed mitochondria into autophagosomes. Among these, the
priming of mitochondria for clearance is a distinct stage and
regulated by coordination and interplay of multiple signaling
pathways [17–19]. The best characterized mitophagy pathway to
date is PINK1 (PTEN induced putative kinase 1)- PRKN (parkin
RBR E3 ubiquitin protein ligase) pathway. PINK1 senses mito-
chondrial damage, accumulates on the outer mitochondrial
membrane, and recruits cytosolic PRKN to mitochondria.
Once recruited, PRKN ubiquitinates outer mitochondrial mem-
brane proteins to enable recognition of the marked mitochon-
dria by receptor proteins such as SQSTM1/p62 (sequestosome 1)
for autophagic elimination [20]. The association of mitophagy
with IPC protection is largely unknown. Nonetheless, PRKN-
mediated mitophagy has been implicated in IPC-mediated car-
dioprotection in Langendorff-perfused rat hearts [21].
We and others recently have demonstrated a protective
role of autophagy in renal IRI [22–26]. Using Pink1 and
Prkn single- as well as double-knockout mouse models, our
latest work has further suggested a protective role of PINK1-
PRKN-mediated mitophagy against renal IRI [27]. The cur-
rent study sought to examine tubular cell autophagy in renal
IPC. We showed that autophagy was activated in proximal
tubules by renal IPC in mice. Impairment of autophagy either
by pharmacological inhibitors or in proximal tubule-specific
atg7 knockout (PT-atg7 KO) mice compromised the benefi-
cial effects of renal IPC, whereas preconditioning with autop-
hagy-inducing Tat-BECN1/Beclin1 peptide afforded IPC-like
renoprotection. In cultured proximal tubular cells, the cyto-
protection of in vitro simulated IPC (sIPC) was also abolished
by autophagy inhibition. These results demonstrate that
autophagy in proximal tubules plays an essential role in the
renoprotection of IPC. Mechanistically, IPC promoted mito-
phagy likely via the PINK1-PRKN pathway. Enhanced clear-
ance of damaged mitochondria attenuated mitochondrial
dysfunction and ROS generation, thus preventing tubular
cell apoptosis and subsequent renal IRI.
Results
Renal IPC protects against renal IRI in C57BL/6 mice
Renal IPC was induced in mice by a brief bilateral renal
ischemia of 15 min followed by 1 h of reperfusion. Mice
were then subjected to a prolonged (27 min) bilateral renal
ischemia followed by reperfusion for up to 48 h to examine
renal IRI. In functional analysis, renal IRI alone induced
severe injury as indicated by increases of blood urea nitrogen
(BUN) and serum creatinine to 286 mg/dl and 1.93 mg/dl,
respectively (Figure 1(a,b), I–R). IPC partially yet significantly
reduced BUN and serum creatinine to 171 mg/dl and
1.29 mg/dl (Figure 1(a,b), IPC + I-R vs I-R). In histological
analysis by hematoxylin-eosin (H-E) staining, renal IRI led to
necrotic tubular cell death in kidney cortex and outer
medulla, which was not significantly affected by renal IPC
(Figure 1(c,d)). In sharp contrast, terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) stain-
ing showed that renal IPC markedly attenuated renal tubule
apoptosis in IRI (Figure 1(e)). Quantitatively, the number of
TUNEL-positive cells per mm2 tissue was reduced from 153
to 68 by IPC (Figure 1(f)). In support of the TUNEL results,
renal IRI induced cleaved/active CASP3 (caspase 3) in kid-
neys, which was significantly suppressed by renal IPC (Figure
1(g)). Together, these results confirm the renoprotective
effects of IPC in our experimental settings. The inhibitory
effects of IPC on tubular cell apoptosis may mainly account
for the improvement of renal function.
Induction of autophagy in proximal tubules during renal IPC
We next determined autophagy induction during renal IPC using
multiple methods. IPC in mice induced an accumulation of the
lipidated form ofMAP1LC3B/LC3B (microtubule associated pro-
tein 1 light chain 3 beta; LC3B-II) and degradation of SQSTM1 in
kidneys (Figure 2(a,b)). Immunohistochemical staining of LC3B
revealed a granular LC3B staining especially along the brush
boarder of proximal tubules in preconditioned kidneys, suggest-
ing the formation of autophagosomes (Figure 2(c)). By quantifi-
cation, the number of LC3B dots per proximal tubule was
increased from 2 in sham group to 6 by renal IPC (Figure 2(d)).
Electron microscopy (EM) confirmed that autophagic vacuoles
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induced by IPC were mainly seen at the apical side of proximal
tubular cells underneath the microvilli (Figure 2(e), circled areas).
The structures of typical autophagic vacuoles were shown at high
magnification (10,000×) EM (Figure 2(e)). Autophagosomes
appeared as double-membrane structures containing cytoplasmic
materials and/or organelles (red arrows). Autolysosomes were
identified as single-membrane structures containing cytoplasmic
components at various stages of degradation (blue arrows). Along
with increased autophagy, the number of reabsorption vacuoles
was remarkably decreased by renal IPC. Sham mice had numer-
ous reabsorption vacuoles in the apical cytoplasm of proximal
tubular cells, including large vacuoles and small coated vesicles,
which were rarely seen in preconditioned kidneys (Figure S1). In
addition to the steady-state LC3B staining and EM images, we
further monitored the dynamics of autophagy using CAGp-RFP-
GFP-LC3 transgenicmice. These autophagy reportermice express
a tandem RFP-GFP-LC3 fusion protein ubiquitously under the
control of a CAG promoter [28]. The dual-color fluorescent probe
utilizes the differential stabilities of RFP and GFP in the lysosome
to discriminate between autophagosomes and autolysosomes.
RFP signal is typically maintained despite the acidic lysosomal
environment (pH 4 to 5) whereas GFP loses fluorescence in this
pH range. Therefore, colocalization of GFPwith RFP fluorescence
in a particle indicates an autophagosome and a RFP-only signal
without GFP is considered an autolysosome [28,29]. Using this
mouse model, our recent work has demonstrated the dynamic
changes of autophagy in proximal tubules during kidney fibrosis
induced by obstructive uropathy [30]. In the current study, com-
pared to sham control that had minimal amounts of GFP-LC3
and RFP-LC3 puncta indicating a low basal level of autophagy,
renal IPC significantly induced the formation of autophagosomes
as well as the maturation to autolysosomes in proximal tubules
a
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Figure 1. Renal IPC protects against renal IRI in C57BL/6 mice. Mice were subjected to 15-min bilateral renal ischemia followed by 1 h of reperfusion to induce renal
IPC. To induce renal IRI, mice were subsequently treated with 27-min bilateral renal ischemia followed by 24 to 48 h of reperfusion (I-R) (sham: n = 3; I-R: n = 7; IPC +
I-R: n = 10). Blood and kidneys were collected at the indicated time points for renal function, histology and immunoblot analyses. (a) BUN. (b) Serum creatinine. Data
are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group. (c) Representative histology of
renal cortex and outer medulla H-E staining. Scale bar: 50 µm. (d) Pathological score of tubular damage. (e) Representative images of TUNEL staining. Scale bar:
50 µm. (f) Quantification of TUNEL-positive cells. Data in (d and f) are expressed as mean ± SD. *, P < 0.05, significantly different from I-R group. (g) Representative
blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of the sham sample was
arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05,
significantly different from the sham group; #, P < 0.05, significantly different from I-R group.
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(Figure 2(f)). Quantification of LC3 puncta showed that the
number of autophagosomes per proximal tubule was increased
from 5 in sham mice to 18 by renal IPC (Figure 2(g), yellow).
There were 3 autolysosomes per proximal tubule in the sham
group, which was increased to 41 in preconditioned mice (Figure
2(g), red-only). We then calculated the autophagic flux rate using
the number of autolysosomes divided by the total number of red
puncta. Shammice had a basal rate of 36% autophagic flux, which
was significantly increased to 68% by IPC (Figure 2(h)). These
results provide definite evidence that autophagy is induced in
proximal tubules following renal IPC. We further monitored the
effects of IPC on autophagy during subsequent renal IRI. Unlike
the studies in the heart and brain [9,11], renal IPC did not change
the induction of general autophagy during prolonged ischemia in
the kidney. Mice in renal IRI group and in IPC + renal IRI group
had comparable extents of LC3B-II accumulation and degrada-
tion of SQSTM1 (Figure S2(a)). Morphological examination in
autophagy reporter mice confirmed that IPC did not further
enhance IRI-induced autophagosome formation and maturation
to autolysosomes in kidney proximal tubules (Figure S2(b–d)).
The renoprotective effects of IPC are abrogated by
autophagy inhibitors and in PT-atg7 KO mice
To determine the role of autophagy in IPC renoprotection,
C57BL/6 mice were pretreated with IPC and then subjected to
renal IRI in the absence or presence of chloroquine or 3-methy-
ladenine, two pharmacological inhibitors of autophagy. The
effects of these inhibitors on autophagy were first verified by
immunoblot analysis of LC3B and SQSTM1. As shown in Figure
S3(a), renal IPC led to LC3B-II accumulation and SQSTM1
degradation. By preventing autolysosomal acidification, chloro-
quine enhanced LC3B-II accumulation and prevented SQSTM1
a
b
c
d
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Figure 2. Induction of autophagy in proximal tubules during renal IPC. C57BL/6 (a–e) and CAGp-RFP-GFP-LC3 (f–h) mice were subjected to renal IPC only without
subsequent renal IRI (C57BL/6 mice: sham: n = 3; IPC: n = 6; CAGp-RFP-GFP-LC3 mice: n = 3 for each). Kidneys were collected after preconditioning for histological
and immunoblot analyses. (a) Representative blots of LC3B and SQSTM1. ACTB was used as a loading control. (b) Densitometric analysis of LC3B-II and SQSTM1. After
normalization with ACTB, the protein signals of the sham were arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold
changes. (c) Representative images of immunohistochemical staining of LC3B. Scale bar: 20 µm. (d) Quantitative analysis of punctate LC3B staining. Data in (b and d)
are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group. (e) Representative electron micrographs showing autophagic vacuoles (arrows)
(n = 2 for each). Scale bar: 2 µm (3 upper panels) and 200 nm (6 lower panels). (f) Representative images of GFP-LC3 and RFP-LC3 fluorescence staining. Scale bar:
15 µm. (g) Quantitative analysis of yellow and red LC3 puncta. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05,
values of red LC3 puncta significantly different from the relevant values of yellow LC3 puncta. (h) Analysis of autophagic flux rate. Data are expressed as mean ± SD.
*, P < 0.05, significantly different from the sham group.
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degradation. 3-methyladenine, via inhibiting autophagosome
formation, reduced both LC3B-II accumulation and SQSTM1
degradation. Similarly, these inhibitors also suppressed autop-
hagy activation during subsequent renal IRI (Figure S3(b and c)).
We then examined the effects of chloroquine and 3-methylade-
nine on kidney injury. In the absence of the inhibitors, IPC
prevented renal function loss, as indicated by the decreases of
BUN and serum creatinine (Figure S3(d and e), saline). Both
chloroquine and 3-methyladenine abolished the beneficial
effects of renal IPC (Figure S3(d and e)), suggesting that autop-
hagy is indispensable for IPC renoprotection during renal IRI.
To verify the pharmacological results, we further examined
PT-atg7 KO mice in which Atg7 was specifically ablated from
kidney proximal tubules [23]. The inhibitory effects of Atg7
deletion on renal IPC-induced autophagy was confirmed by
immunoblots of LC3B and SQSTM1 (Figure 3(a)). Renal IRI
without IPC led to kidney injury in both floxed control (PT-
Atg7 FC) and PT-atg7 KO mice. Consistent with our previous
work [23], PT-atg7 KO mice were more sensitive to the injury
as compared to floxed control mice, showing more severe
renal function loss and tubular cell death (Figure 3(b–e), no
IPC, PT-atg7 KO vs PT-Atg7 FC). Renal IPC attenuated the
BUN and serum creatinine increases in floxed control mice
(Figure 3(b,c), PT-Atg7 FC), whereas the effect of IPC was
completely lost in PT-atg7 KO mice (Figure 3(b,c), PT-atg7
KO). Morphologically, IPC was unable to inhibit tubular cell
necrosis in both floxed control and PT-atg7 KO mice (Figure
3(d,e)). Nevertheless, IPC significantly reduced tubular cell
b
c
d
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e
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Figure 3. The protective effects of IPC against renal IRI are abrogated in PT-atg7 KO mice. (a) Floxed control (PT-Atg7 FC) and PT-atg7 KO mice were treated with
sham or IPC and kidneys were collected for immunoblot analysis of LC3B and SQSTM1 (n = 3 for each). ACTB was used as a loading control. Floxed control and PT-atg
7 KO mice were subjected to: (1) sham (n = 3 for each); (2) I-R (n = 8 for FC; n = 9 for KO); (3) IPC + I-R (n = 10 for each). Blood and kidneys were collected at the
indicated time points for renal function, histology and immunoblot analyses. (b) BUN. (c) Serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly
different from the sham group; #, P < 0.05, significantly different from I-R group. (d) Representative histology of renal cortex and outer medulla H-E staining. Scale
bar: 50 µm. (e) Pathological score of tubular damage. (f) Representative images of TUNEL staining. Scale bar: 50 µm. (g) Quantification of TUNEL-positive cells. Data in
(e and g) are expressed as mean ± SD. *, P < 0.05, significantly different from I-R group. (h) Representative blots and densitometric analysis of cleaved CASP3. ACTB
was used as a loading control. After normalization with ACTB, the protein signal of the sham was arbitrarily set as 1, and the signals of other conditions were
normalized to the sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly
different from I-R group.
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apoptosis in floxed control mice and this effect was eliminated
in PT-atg7 KO mice, as shown by the analyses of TUNEL
staining and CASP3 cleavage (Figure 3(f–h)). Together, these
results provide compelling evidence that autophagy plays an
essential role in the protective effect of IPC against subsequent
renal IRI.
Pharmacological preconditioning with Tat-BECN1
activates autophagy and protects against renal IRI in
C57BL/6 mice
To mimic the effect of renal IPC on autophagy, we pretreated
C57BL/6 mice with a recently identified specific autophagy-
inducing peptide, Tat-BECN1 [31]. Our pilot test indicated
that autophagy was induced in kidneys at 3 to 4 h after Tat-
BECN1 injection. We therefore chose to administer the pep-
tide 4 h before the onset of 27-min ischemia and determined
its effect on kidney injury. Activation of autophagy by Tat-
BECN1 was first indicated by LC3B-II induction and
SQSTM1 degradation in pretreated kidneys (Figure S4(a and
b)). Immunohistochemical staining of LC3B further revealed
that compared to scramble peptide, Tat-BECN1 pretreatment
enhanced the autophagosome formation in proximal tubules,
with the number of punctate LC3B increased from 2 to 6 per
proximal tubule (Figure S4(c and d)). The dynamic changes of
autophagy were also determined in autophagy reporter mice.
Tat-BECN1 treatment significantly increased the formation of
both autophagosomes and autolysosomes (Figure S4(e and f)).
Consistently, autophagic flux was also elevated by Tat-BECN1
(Figure S4(g)). These results suggest that pharmacological
preconditioning with Tat-BECN1 activates autophagy in kid-
ney proximal tubules. We then monitored kidney injury. Mice
pretreated with Tat-BECN1 showed significantly lower BUN
and serum creatinine during renal IRI as compared to scram-
ble peptide-injected group (Figure 4(a,b)). Similar with the
effects of renal IPC, Tat-BECN1 preconditioning did not
ba
c
d
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g
Figure 4. Pharmacological preconditioning with Tat-BECN1 protects against renal IRI in C57BL/6 mice. C57BL/6 mice were pretreated with Tat-BECN1 and its control
peptide (Tat-Scramble) at a single dose of 20 mg/kg i.p. injection. Four h after preconditioning, mice were subjected to 27-min bilateral renal ischemia followed by 24
to 48 h of reperfusion (sham: n = 3 for each; Tat-Scramble + I-R: n = 8; Tat-BECN1 + I-R: n = 10). Blood and kidneys were collected at the indicated time points for
renal function, histology and immunoblot analyses. (a and b) BUN and serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the
sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group. (c) Representative histology of renal cortex and outer medulla H-E staining. Scale bar:
50 µm. (d) Pathological score of tubular damage. (e) Representative images of TUNEL staining. Scale bar: 50 µm. (f) Quantification of TUNEL-positive cells. Data in (d
and f) are expressed as mean ± SD. *, P < 0.05, significantly different from Tat-Scramble + I-R group. (g) Representative blots and densitometric analysis of cleaved
CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of Tat-Scramble + sham was arbitrarily set as 1, and the signals of other
conditions were normalized to the Tat-Scramble + sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham
group; #, P < 0.05, significantly different from Tat-Scramble + I-R group.
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prevent tubular necrosis (Figure 4(c,d)). Nevertheless, the
peptide remarkably suppressed tubular apoptosis in renal
IRI. The number of TUNEL-positive cells was reduced from
166 in Tat-Scramble group to 78 by Tat-BECN1, which also
reduced the cleavage or activation of CASP3 (Figure 4(e–g)).
These results further support an important role of autophagy
in the protective effect of preconditioning. Pharmacological
upregulation of autophagy (pretreatment) may be an effective
approach for the prevention and treatment of renal IRI.
Both renal IPC and Tat-BECN1 preconditioning
enhance mitophagy in proximal tubules during
subsequent renal IRI in mice
Removal of protein aggregates and damaged organelles by
autophagy is critical for autophagy-dependent protection
under various stress conditions. In the heart, mitochon-
dria are the important targets of autophagy elimination
(mitophagy) during ischemia-reperfusion or oxidative
stress [32,33]. To understand how autophagy in IPC pro-
tects kidneys, we examined the effects on mitophagy. As
shown in Figure 5(a), PINK1, an important mitophagy
regulator that promotes the recruitment of PRKN on the
surface of damaged mitochondria to initiate mitophagy,
was accumulated in kidneys following renal IRI.
Activation of PINK1 was accompanied with loss of mito-
chondrial mass, as indicated by the decreases of multiple
mitochondrial proteins including inner membrane
COX4I1 (cytochrome c oxidase subunit 4I1) and IMMT/
MIC60 (inner membrane mitochondrial protein) as well
as outer membrane TOMM20 (translocase of outer mito-
chondrial membrane 20) (Figure 5(a), I-R)). Due to the
low sensitivity of this biochemical analysis of mitophagy,
renal IPC did not show obvious effects on the loss of
mitochondrial mass (Figure 5(a), IPC + I-R vs I-R).
HIGH MAG
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Figure 5. Both renal IPC and Tat-BECN1 preconditioning enhance mitophagy in proximal tubules during subsequent renal IRI in mice. (a) C57BL/6 mice were
subjected to: (1) sham (n = 3); (2) I-R (n = 7); (3) IPC + I-R (n = 10). Kidneys were collected for immunoblot analysis of PINK1, COX4I1, IMMT/MIC60, and TOMM20.
PPIB (peptidylprolyl isomerase B) was used as a loading control. Mito-QC mice were subjected to: (1) sham (n = 3); (2) IPC (n = 3); (3) I-R (n = 4); (4) IPC + I-R (n = 5).
Kidneys were collected to determine mitophagy flux by fluorescence microscopy. (b) Representative images of the formation of mitolysosomes. Scale bar: 20 µm for
low magnification and 5 µm for high magnification. (c) Quantitative analysis of the number of mitolysosomes per 400× field (renal cortex and outer stripe of outer
medulla, glomeruli excluded). Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from
I-R group. Furthermore, mito-QC mice were pretreated with Tat-BECN1 and its control peptide (Tat-Scramble) at a single dose of 20 mg/kg i.p. injection. Four h after
preconditioning, mice were subjected to sham surgery or 27-min bilateral renal ischemia followed by 48 h of reperfusion (n = 3 for each). Kidneys were collected to
determine mitophagy flux by fluorescence microscopy. (d) Representative images of the formation of mitolysosomes. Scale bar: 20 µm. (e) Quantitative analysis of
the number of mitolysosomes per 400× field (renal cortex and outer stripe of outer medulla, glomeruli excluded). Data are expressed as mean ± SD. *, P < 0.05,
significantly different from the sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group.
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To further measure mitophagy and distinguish between
different cell types within the kidney, we utilized the
newly established mitophagy reporter mouse model
named mito-QC (mito-quality control) [34]. Mito-QC
mice express a tandem mCherry-GFP protein fused to
the mitochondrial targeting sequence of FIS1 (fission,
mitochondrial 1) that is pH sensitive. Under steady
state, mito-QC displays both red (mCherry) and green
(GFP) fluorescence, giving a yellow staining of mitochon-
drial networks. Upon mitophagy, mitochondria are deliv-
ered to lysosomes where GFP signal is quenched in the
acidic environment but mCherry fluorescence is stable
and maintained. Therefore, the appearance of mCherry-
only puncta that colocalize with LAMP1 (lysosomal-
associated membrane protein 1) indicates the formation
of mitolysosomes. This assay allows a binary, endpoint
readout of mitophagy and assessment of mitochondrial
architecture in vivo [34,35]. Using this mouse model, we
analyzed mitophagy in kidney tissues under control, pre-
conditioning, and renal IRI conditions. Notably, sham
control mice had a high basal level of mitophagy in
some cortical proximal tubules. In these renal tubules,
mitolysosomes displayed a polarized distribution and
positioned predominantly at the apical side toward the
lumen (Figure 5(b), sham, mCherry). In contrast to
these highly mitophagic proximal tubules in renal cortex,
proximal tubules in the inner cortex and the outer stripe
of outer medulla (S3 segment that is highly susceptible to
renal IRI) showed minimal mitochondrial turnover under
basal condition (Figure S5(a and b)). Mitophagy in glo-
meruli was also much less than those cortical proximal
tubules (Figure S5(b)). Following renal IRI, mitophagy
was significantly induced in proximal tubules. More prox-
imal tubules in both renal cortex and S3 segment had
apical-positioned mitolysosomes as compared to sham
mice (Figure 5(b), I-R, mCherry). The polarized distribu-
tion and increased formation of mitolysosomes were
further revealed in individual proximal tubules at
a higher magnification (Figure 5(b), high mag).
Importantly, renal IPC did not induce mitophagy on its
own (Figure 5(b), IPC, mCherry) but further enhanced
the intensity of mitolysosome formation in renal IRI
(Figure 5(b), IPC + I-R, mCherry). The numbers of mito-
lysosomes per 400× field (cortex and outer stripe of outer
medulla, glomeruli excluded) were counted for quantifica-
tion. Sham control mice had an average of 364 mitolyso-
somes, which was increased to 583 in I-R mice and
further elevated to 793 in IPC + I-R group (Figure 5
(c)). In addition to renal IPC, pharmacological precondi-
tioning with Tat-BECN1 also enhanced mitolysosome for-
mation and mitophagy flux in kidney proximal tubules of
mito-QC mice. In sham control animals, Tat-BECN1 pre-
treatment had a marginal effect, increasing the number of
mitolysosomes from 293 to 325 (Figure 5(d,e), Tat-BECN
1 + sham vs. Tat-Scramble + sham). Following renal IRI,
650 mitolysosomes were detected in scramble peptide-
pretreated group (Figure 5(d,e), Tat-Scramble + I-R),
which was significantly elevated to 830 by Tat-BECN1
preconditioning (Figure 5(d,e), Tat-BECN1 + I-R).
Together, these results suggest that renal IPC may protect
the kidney by promoting mitophagy in proximal tubules
during subsequent renal IRI.
In vitro sIPC attenuates prolonged CCCP-induced
apoptosis in renal proximal tubular cells
To further delineate the role of autophagy/mitophagy in IPC
renoprotection, we established an in vitro model where sIPC
was induced in rat proximal tubular cells (RPTC) by 30 min
of ATP-depletion with carbonyl cyanide 3-chlorophenylhy-
drazone (CCCP) followed by 40 min of recovery. The cells
were then incubated with prolonged CCCP for 3 h followed
by 2 h of recovery to model in vivo renal IRI. The cytopro-
tective effects of sIPC in cultured proximal tubular cells were
verified by morphological and biochemical analyses.
Prolonged CCCP treatment led to 46% apoptosis in RPTC
cells, which was significantly reduced to 24% by sIPC. The
apoptotic cells displayed a shrunken configuration with apop-
totic bodies and condensed or fragmented nuclei (Figure 6(a,
b)). Consistently, CCCP-induced caspase activation was also
attenuated by sIPC. There was a 7-fold increase of cleaved
CASP3 expression in prolonged CCCP-treated cells, which
was reduced to 3-fold by sIPC (Figure 6(c)). In addition to
CCCP, we also used sodium azide for ATP depletion to mimic
in vivo IPC and IRI. Consistently, sIPC suppressed azide-
induced apoptosis in RPTC cells (Figure S6).
Autophagy is activated by in vitro sIPC in RPTC cells
We then examined autophagy in preconditioned RPTC
cells. As shown in Figure S7(a), sIPC induced both LC3B-
II accumulation and SQSTM1 degradation in RPTC cells,
suggesting an activation of autophagy under this condi-
tion. Upregulation of LC3B-II was further enhanced in
the presence of chloroquine, indicating an increased
LC3B-II turnover and induction of autophagic flux
(Figure S7(b)). The dynamic changes of autophagy were
further monitored in RPTC cells transfected with
a tandem fluorescent-tagged LC3 (mRFP-GFP-LC3).
Control cells had a very low basal level of autophagy as
indicated by minimal punctate staining (Figure S7(c),
control). sIPC increased the formation of both autopha-
gosomes and autolysosomes (Figure S7(c), sIPC).
Quantitatively, the number of autophagosomes (yellow
puncta) per cell was increased from 6 in control cells to
15 in preconditioned cells. The number of autolysosomes
(red-only puncta) per cell was also remarkably elevated
from 2 in control group to 18 by sIPC (Figure S7(d)).
Accordingly, autophagic flux rate was increased from 27%
in control to 54% by sIPC (Figure S7(e)). Together, these
results suggest that autophagy is induced in precondi-
tioned RPTC cells. Notably, consistent with in vivo find-
ings, in vitro sIPC did not have additional effects on
general autophagy induced during subsequent CCCP
treatment of RPTC cells, as shown by immunoblot analy-
sis of LC3B and SQSTM1 (Figure S8(a)) as well as mor-
phological examination of autophagosomes,
autolysosomes and autophagic flux (Figure S8(b–d)).
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The cytoprotection of in vitro sIPC is diminished by
autophagy inhibitors in RPTC cells
To elucidate the role of autophagy in the cytoprotection of
in vitro preconditioning, we examined the effects of autop-
hagy inhibitors, chloroquine and 3-methyladenine. The inhi-
bitory effects of these drugs on autophagy were verified by
LC3B immunoblots (Figure 7(d and e), LC3B). In the absence
of autophagy inhibitors, prolonged CCCP treatment induced
38% apoptosis in RPTC cells, which was reduced to 18% by
sIPC (Figure 7(a,b), CCCP-R vs sIPC + CCCP-R, no inhibi-
tors). However, the protective effects of sIPC were largely
compromised by autophagy inhibitors. As shown in Figure 7
(a,b), in the presence of chloroquine or 3-methyladenine,
sIPC only slightly suppressed tubular cell apoptosis (CCCP-
R vs sIPC + CCCP-R, chloroquine or 3-methyladenine). By
calculation, sIPC had 51% inhibitory efficiency on apoptosis
in the cells with intact autophagy, which was reduced to 16%
by chloroquine and to 9% by 3-methyladenine, respectively
(Figure 7(c)). Both chloroquine and 3-methyladenine sensi-
tized RPTC cells to prolonged CCCP-induced apoptosis
(Figure 7(a,b), CCCP-R, no inhibitors vs CCCP-R, chloro-
quine or 3-methyladenine). Consistent with the morphologi-
cal observations, sIPC significantly suppressed caspase
activation in prolonged CCCP-treated cells, but this effect
disappeared when the inhibitors impaired autophagy (Figure
7(d,e), cleaved CASP3). Together, these results confirm the
involvement of autophagy in the sIPC protection in vitro
during CCCP treatment of renal tubular cells.
In vitro sIPC promotes mitophagy in RPTC cells during
prolonged CCCP treatment
To further investigate the mechanism that contributes to the
cytoprotection of sIPC, we performed a comprehensive ana-
lysis of mitophagy at various stages (initiation, progression,
and degradation) in the in vitro model. First, RPTC cells were
transfected with a plasmid encoding GFP-LC3 and incubated
with MitoTracker Red CMXRos to label autophagosomes and
mitochondria, respectively. The cells were then subjected to
sIPC and prolonged CCCP treatment in the presence of
chloroquine to block autolysosomal degradation. After treat-
ment, we measured colocalization of mitochondria with
autophagosomes by fluorescence microscopy. Consistent
with our previous work [36], mitochondria in control RPTC
cells were filamentous with a tubular or thread-like appear-
ance and often interconnected to form a network (Figure S9
(a), control, MitoTracker Red). A few GFP-LC3 puncta were
detected, indicating a basal level of autophagy in control cells
(Figure S9(a), control, GFP-LC3). However, GFP-LC3 puncta
containing mitochondria were rarely seen in RPTC cells
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Figure 6. In vitro sIPC attenuates prolonged CCCP-induced apoptosis in RPTC cells. In vitro sIPC was induced by incubating RPTC cells with 20 μM CCCP for 30 min
followed by 40 min of recovery. The cells were then treated with prolonged CCCP (20 μM) for 3 h followed by 2 h of recovery to model in vivo renal IRI. Cells were
collected for analysis of apoptosis by morphology and caspase activation. (a) Representative images of phase contrast and fluorescence microscopy showing cellular
and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. (c) Representative blots and densitometric analysis of cleaved CASP3.
ACTB was used as a loading control. After normalization with ACTB, the protein signal of the control was arbitrarily set as 1, and the signals of other conditions were
normalized to the control to calculate fold changes. Data in (b and c) are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #,
P < 0.05, significantly different from CCCP-R group.
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under control condition (Figure S9(a), control, overlap). sIPC
alone enhanced the formation of GFP-LC3 puncta but only
a very few were co-stained with mitochondria (Figure S9(a),
sIPC). Following prolonged CCCP treatment, numerous GFP-
LC3 puncta appeared in RPTC cells (Figure S9(a), CCCP-R,
GFP-LC3). Meanwhile, mitochondria became fragmented into
short rods or spheres and the mitochondrial network broke
down (Figure S9(a), CCCP-R, MitoTracker Red). Notably,
a portion of these fragmented mitochondria were colocalized
with GFP-LC3 puncta as shown in the enlarged overlapping
image, indicating the formation of mitophagosomes (Figure
S9(b), CCCP-R). sIPC further promoted this colocalization,
suggesting an increased autophagic sequestration of damaged
mitochondria by preconditioning (Figure S9(b), sIPC +
CCCP-R). We then performed quantitative analysis.
Consistent with the data in Figure S8, sIPC did not alter the
induction of general autophagy during prolonged CCCP
treatment, as indicated by similar amount of total GFP-LC3
puncta (autophagosomes) (Figure S9(c)). Nevertheless, the
number of colocalizing GFP-LC3 puncta per cell (mitophago-
somes) was significantly increased from 16 in CCCP-R group
to 29 in sIPC + CCCP-R group (Figure S9(d)). Accordingly,
the percentage of colocalizing GFP-LC3 puncta was also
increased from 19% to 35% by sIPC (Figure S9(e)).
Together, these results demonstrate that sIPC enhances the
initiation of mitophagy (early mitophagy) in RPTC cells dur-
ing subsequent CCCP treatment.
To visualize the delivery of mitophagosomes to hydro-
lase-containing lysosomes, we transfected RPTC cells with
COX8-EGFP-mCherry, a tandem fluorescent-tagged mito-
chondrial targeting sequence of inner membrane protein
COX8 (cytochrome c oxidase subunit 8). This approach is
based on the same principle validated in mito-QC
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Figure 7. The cytoprotection of in vitro sIPC is diminished by autophagy inhibitors in RPTC cells. RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-
R in the absence or presence of chloroquine (20 μM) and 3-methyladenine (10 mM). Both inhibitors were used for 1-h pretreatment and during 2-h recovery from
prolonged CCCP treatment. Cells were collected for morphological and immunoblot analyses. (a) Representative images of phase contrast and fluorescence
microscopy showing cellular and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. Data are expressed as mean ± SD. *,
P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group. (c) Analysis of apoptosis inhibitory efficiency by sIPC.
Data are expressed as mean ± SD. *, P < 0.05, significantly different from the group without inhibitors. (d and e) Immunoblots of LC3B and cleaved CASP3. ACTB was
used as a loading control. The molecular mass marker lanes were labelled as kDa. For densitometric analysis of cleaved CASP3, after normalization with ACTB, the
protein signals of the control were arbitrarily set as 1, and the signals of other conditions were normalized to the control to calculate fold changes. Data are
expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group.
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transgenic mice and has been effective for monitoring
mitophagy flux in different types of cultured cells
[37,38]. Control RPTC cells showed a yellow staining of
filamentous mitochondria with the merge of both green
(EGFP) and red (mCherry) signals (Figure S10(a), con-
trol). In contrast, mitochondria in prolonged CCCP-
treated cells became fragmented and distinct red-only
puncta appeared, indicating the formation of mitolyso-
somes (Figure S10(a), CCCP-R). Importantly, more red-
only puncta were induced by sIPC, suggesting a higher
mitochondrial turnover under this condition (Figure S10
(a), sIPC + CCCP-R). The delivery of fragmented mito-
chondria to lysosomes was completely abolished by chlor-
oquine, further supporting the role of autophagy in
mediating mitochondria turnover in our in vitro model
(Figure S10(a), CQ + sIPC + CCCP-R). Quantitatively,
prolonged CCCP treatment led to an average of 9 mito-
lysosomes per cell, which was markedly increased to 23
by sIPC (Figure S10(b)). Together, these results indicate
that sIPC also promotes the progression of mitophagy
from mitophagosomes to mitolysosomes (late mitophagy)
in RPTC cells during subsequent CCCP treatment.
Mitochondrial degradation and clearance within the lyso-
some represents the completion of mitophagy flux. To moni-
tor this final step, we stained RPTC cells with MitoTracker
Red CMXRos and measured the amount of remaining mito-
chondria after CCCP treatment. Control RPTC cells displayed
an intact filamentous mitochondrial network, with 17% of
cellular area positively stained with the mitochondrial marker
(Figure S11(a and b), control). Prolonged CCCP induced
mitochondrial fragmentation and reduced the mitochondrial
mass to 12% of cellular area (Figure S11(a and b), CCCP-R).
Pretreatment with sIPC enhanced the clearance of damaged
mitochondria, leading to a further decrease of MitoTracker
Red staining to 9.7% of cellular area (Figure S11(a and b),
sIPC + CCCP-R). To verify whether this mitochondrial degra-
dation is autophagy-dependent, we examined the effect of
chloroquine. Prolonged CCCP-induced degradation of mito-
chondria was partially suppressed by chloroquine, and more
importantly, the promoting effects of sIPC on mitochondrial
clearance was also abolished (Figure S11(a and b), + CQ).
Together, these results suggest that autophagy indeed contri-
butes to the clearance of impaired mitochondria and sIPC
increases mitophagy degradation and flux in RPTC cells dur-
ing prolonged CCCP treatment.
In vitro sIPC improves mitochondrial function and
reduces ROS generation in prolonged CCCP-treated RPTC
cells
To determine whether an increased clearance of damaged mito-
chondria by sIPC-mediatedmitophagywould improvemitochon-
drial function, we first analyzed the effect on mitochondrial
membrane potential in CCCP-treated RPTC cells using 5,5ʹ,6,6ʹ-
tetrachloro-1,1ʹ,3,3ʹ-tetraethylbenzimidazolylcarbocyanine iodide
(JC-1). JC-1 is a dichromatic dye that exhibits potential-
dependent accumulation in mitochondria. It exists as either
a green-fluorescent monomer at depolarizing mitochondria or
a red-fluorescent aggregate at polarizing mitochondria, thus
allowing for the assessment of mitochondrial polarization states.
The ratio of green to red fluorescence depends only on the
mitochondrial membrane potential and not on other factors
such as mitochondrial size, shape and density that may influence
single-component fluorescence signals [39]. In control RPTC
cells, mitochondria were marked by punctate red fluorescence of
JC-1 with green signal barely detected, indicating goodmitochon-
drial membrane potential (Figure 8(a), control). In sharp contrast,
prolonged CCCP treatment led to a drastic decrease of red JC-1
fluorescence in RPTC cells; instead, many cells displayed intense,
mostly-diffuse green monomer fluorescence (Figure 8(a), CCCP-
R). The shift from red to green JC-1 fluorescence indicated the loss
of mitochondrial membrane potential in these cells. Of interest,
sIPC significantly suppressed mitochondrial depolarization dur-
ing prolonged CCCP treatment. The amount of punctate red JC-1
fluorescence was increased by sIPC, which was accompanied by
a decrease of green monomer JC-1 fluorescence in both the
amount and the intensity (Figure 8(a), sIPC + CCCP-R).
Quantitative analysis further verified the morphological observa-
tions. The ratio of green to red fluorescence in control cells was
0.03. Following prolonged CCCP treatment, this ratio was
induced to 3.9 and sIPC remarkably reduced it to 1.3 (Figure 8
(b)).Mitochondrial membrane potential is critical formaintaining
the physiological function of the respiratory chain to generate
ATP. We then examined the effects of sIPC on ATP production.
Control RPTC cells had 4.9 nM ATP/µg protein on average,
which was reduced to 1.9 in prolonged CCCP-treated cells. sIPC
partially yet significantly improved the capacity of the cells to
generate energy and under this condition, the amount of ATP
was increased to 3.2 nM/µg protein (Figure 8(c)). Together, these
results suggest that sIPC, via enhancing autophagic clearance of
damaged mitochondria, plays an important role in mitochondrial
quality control in prolonged CCCP-treated RPTC cells.
ROS generated by damaged mitochondria contributes sig-
nificantly to oxidative stress, which plays an important role in
IRI in many tissues including the kidney. To further determine
the association of mitophagy with the renoprotection of sIPC,
we measured ROS generation in RPTC cells using the fluoro-
genic probe, CellROX Deep Red. As shown in Figure 8(d),
control cells were negative of the staining as this cell-
permeable dye is non-fluorescent in a reduced state.
Following prolonged CCCP treatment, intense red fluores-
cence appeared, indicating ROS production. Remarkably,
sIPC reduced ROS generation, and this beneficial effect was
compromised in the presence of chloroquine. The specificity of
this reagent in detecting oxidative stress was further confirmed
by the inhibitory effects of N-acetylcysteine (NAC), an anti-
oxidant compound (Figure 8(d)). Together with the data pre-
sented above, these results suggest that, by promoting mito-
phagy, sIPC attenuates the generation of ROS and prevents
tubular cell apoptosis during subsequent CCCP treatment.
Knockdown of Pink1 impairs mitophagy flux and
eliminates sIPC-mediated cytoprotection in prolonged
CCCP-treated RPTC cells
As shown in Figure 5, renal IRI activated PINK1 in kidneys,
which was accompanied by the degradation of multiple mito-
chondrial proteins and more importantly, the induction of
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mitophagy flux in proximal tubules. To gain some insights into
the regulation of mitophagy in our experimental models, we
examined the expression of several mitophagy-related proteins
in the mitochondrial fractions of RPTC cells. sIPC-only treat-
ment induced a moderate PINK1 accumulation in mitochon-
drial fractions. Following prolonged CCCP treatment, the
mitochondrial accumulation of PINK1 was further enhanced
(Figure 9(a), PINK1). Consistently, PRKN, an E3-ubiquitin
ligase that can be recruited onto the surface of damaged mito-
chondria by activated PINK1 to initiate mitophagy, was also
accumulated in mitochondria at a moderate level in response
to sIPC-only and further increased after prolonged CCCP treat-
ment (Figure 9(a), PRKN). In addition to these two regulators,
BNIP3L/NIX (BCL2 interacting protein 3 like), a mitophagy
receptor protein, was also induced and accumulated in mito-
chondria under both sIPC and prolonged CCCP conditions
(Figure 9(a), BNIP3L/NIX). Similar changes were also shown
in DNM1L (dynamin 1 like), a well-known mitochondrial fis-
sion regulator (Figure 9(a), DNM1L). In contrast, the mitochon-
drial expression of FUNDC1 (FUN14 domain containing 1),
another receptor protein that has been shown to induce mito-
phagy under hypoxia conditions, was not altered by sIPC alone
but significantly reduced during prolonged CCCP treatment
(Figure 9(a), FUNDC1). These results suggest a possibility that
multiple signaling pathways might contribute to the regulation
of sIPC-related mitophagy in our experimental models.
To further determine the role of PINK1-PRKN pathway, we
infected RPTC cells with retroviral Pink1 shRNA constructs and
selected stable cells with puromycin. The efficiency of gene
silencing was verified by immunoblot analysis of PINK1.
Compared with negative control vector, the expression of
PINK1 was suppressed by all 4 Pink1 shRNAs in the stable
cells, with A and C more effective than B and D (Figure 9(b)).
We therefore chose the cells infected with negative control,
Pink1 shRNA A, and Pink1 shRNA C for further analysis.
These cells were transiently transfected with COX8-EGFP-
mCherry and the delivery of mitophagosomes to lysosomes to
form mitolysosomes was examined. In negative control trans-
fection cells, the formation of mitolysosomes was detected at
a very low basal level under control condition and mitochondria
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Figure 8. In vitro sIPC suppresses mitochondrial depolarization, improves ATP production and reduces ROS generation in prolonged CCCP-treated RPTC cells. RPTC
cells were incubated with 1 μg/ml JC-1 for 1 h and then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Live cells were collected 1 h after reperfusion for
fluorescence microscopy. (a) Representative images of JC-1 staining showing red fluorescence of JC-1 aggregate and green signal of monomer. Scale bar: 50 μm. (b)
Quantification of the ratio of green to red fluorescence. (c) RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Thirty min after reperfusion cells
were collected for quantitative determination of ATP by a luciferin-luciferase luminescence assay. Data in (b and c) are expressed as mean ± SD. *, P < 0.05,
significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group. (d) RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC +
CCCP-R; (4) CQ + sIPC + CCCP-R; (5) NAC + CCCP-R. After treatment cells were incubated with 5 μM CellROX Deep Red reagent for 30 min. ROS generation was
visualized by fluorescence microscopy. Scale bar: 50 μm.
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formed a yellow-stained network (Figure 9(c), negative control,
control). Following prolonged CCCP treatment, mitochondria
became fragmented and distinct red-only puncta appeared,
indicating the formation of mitolysosomes (Figure 9(c), nega-
tive control, CCCP-R). More red-only puncta were induced by
sIPC in prolonged CCCP-treated cells, suggesting an enhanced
mitophagy flux (Figure 9(c), negative control, sIPC + CCCP-R).
Quantitatively, an average of 7 mitolysosomes per cell was
induced during prolonged CCCP treatment, which was mark-
edly increased to 19 by sIPC (Figure 9(d), negative control). In
contrast, the formation of mitolysosomes was almost completely
blocked in Pink1 shRNA knockdown cells under all 3 treatment
conditions (Figure 9(c,d), Pink1 shRNA A, Pink1 shRNA C).
These results suggest that PINK1-PRKN pathway plays a central
role in mitophagy initiation and progression in this experimen-
tal condition.
We next examined the effects of mitophagy inhibition on
sIPC-mediated cytoprotection in RPTC cells. In negative
control transfection cells, prolonged CCCP treatment induced
45% apoptosis, which was reduced to 18% by sIPC (Figure 10(a,
b), negative control). Of note, the protective effects of sIPC were
completely eliminated by mitophagy inhibition. In Pink1
shRNA A cells, 44% apoptosis was induced in response to
prolonged CCCP treatment. sIPC did not afford any cytopro-
tection (Figure 10(a,b), Pink1 shRNA A). The loss of sIPC-
mediated beneficial effects was also shown in Pink1 shRNA
C cells (Figure 10(a,b), Pink1 shRNA C). Consistently, without
mitophagy inhibition sIPC significantly suppressed caspase acti-
vation in prolonged CCCP-treated cells (Figure 10(c,d), nega-
tive control). However, when mitophagy was impaired by Pink1
knockdown, the inhibitory effect of sIPC on caspase activation
dissappeared (Figure 10(c,d), Pink1 shRNA A, Pink1 shRNA C).
In addition, sIPC-mediated mitochondrial protection was also
compromised in these mitophagy-deficient cells. As shown in
Figure 10(e,f), in negative control cells, sIPC prevented the loss
of mitochondrial membrane potential and promoted ATP
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Figure 9. Knockdown of Pink1 inhibits mitophagy flux in CCCP-treated RPTC cells. (a) RPTC cells were subjected to: (1) control; (2) sIPC; (3) CCCP-R; (4) sIPC + CCCP-R.
After treatment mitochondrial fractions were collected for immunoblot analysis of multiple mitophagy-related proteins including PINK1, PRKN, BNIP3L/NIX, FUNDC1
and DNM1L. HSPD1, a mitochondrial matrix protein, was used as a loading control. (b) RPTC cells were infected with retroviral Pink1 shRNA constructs (A–D) and
a negative control (NC) construct. Upon puromycin selection, stable cells were collected for immunoblot analysis of PINK1. PPIB was used as a loading control. Based
on the inhibitory effects, the stable cells (negative control, Pink1 shRNA A, Pink1 shRNA C) were transfected with COX8-EGFP-mCherry and then treated with: (1)
control; (2) CCCP-R; (3) sIPC + CCCP-R. Cells were collected for fluorescence microscopy. (c) Representative images of mitolysosome formation. Scale bar: 10 μm. (d)
Quantitative analysis of the number of mitolysosomes per cell. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #,
P < 0.05, significantly different from CCCP-R group; ^, P < 0.05, significantly different from the corresponding groups in negative control cells.
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production during prolonged CCCP treatment. These beneficial
effects of sIPC were largely lost in Pink1 knockdown cells.
Together, these results provide direct evidence that mitophagy
specifically contributes to the cytoprotective effect of sIPC dur-
ing CCCP treatment of renal tubular cells.
Discussion
Both IPC and autophagy/mitophagy protect against kidney
injury by renal ischemia-reperfusion. However, the connec-
tion between these two in the kidney has not been reported.
Using both in vivo and in vitro models, the current study has
provided the first evidence for a critical role of autophagy/
mitophagy in the protective effect of renal IPC. In this study,
IPC induced autophagy both in mouse proximal tubules and
in cultured renal tubular cells. Inhibition of autophagy by
pharmacological inhibitors (chloroquine and 3-methylade-
nine) or Atg7 deletion specifically from proximal tubules
eliminated the renoprotective effect of IPC. Notably, IPC did
not affect the induction of general autophagy during subse-
quent renal IRI, but it significantly enhanced mitophagy in
proximal tubular cells. Increased clearance of damaged mito-
chondria via mitophagy prevented mitochondrial function
loss, attenuated ROS generation, and alleviated tubular cell
apoptosis and kidney injury. Pink1 knockdown in proximal
tubular cells blocked mitophagy, suggesting a role of the
PINK1-PRKN pathway in IPC-mediated mitophagy. Specific
inhibition of mitophagy also abolished the beneficial effects of
IPC. Moreover, pharmacological preconditioning with Tat-
BECN1 activated autophagy/mitophagy and protected kidneys
against renal IRI, further suggesting potential therapeutic
applications of autophagy/mitophagy in renal IPC.
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Figure 10. In vitro sIPC-mediated cytoprotection is compromised by Pink1 knockdown in RPTC cells. RPTC stable cell lines (negative control, Pink1 shRNA A, Pink1
shRNA C) were established as described in Figure 9. The cells were then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. After treatment cells were collected
for morphological, biochemical and immunoblot analyses. (a) Representative images of phase contrast and fluorescence microscopy showing cellular and nuclear
morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. (c) Representative images of cleaved CASP3 immunoblot. ACTB was used as
a loading control. The molecular mass marker lane was labelled as kDa. (d) Densitometric analysis of cleaved CASP3 immunoblots. After normalization with ACTB, the
protein signals of the control in negative control cells were arbitrarily set as 1, and the signals of other conditions were normalized to calculate fold changes. (e)
Quantitative analysis of JC-1 staining (the ratio of green to red fluorescence). Cells were loaded with 1 μg/ml JC-1 for 1 h prior to CCCP treatment. Live cells were
collected for fluorescence microscopy. (f) Bioluminescence assay of ATP production. Data in (b,d–f) are expressed as mean ± SD. *, P < 0.05, significantly different
from the control group; #, P < 0.05, significantly different from CCCP-R group.
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In this study, a short period of ischemia (15 min) induced
autophagy in kidney proximal tubules within 1 h of reperfu-
sion (Figure 2). Compared to a prolonged renal ischemia (28
to 30 min) that induces autophagy after 6 h of reperfusion
[22], autophagy activation during renal IPC was apparently
much earlier and faster. A rapid induction of autophagy
within minutes in response to sub-lethal ischemia has also
been shown in the heart and liver [9,10,15]. Consistently,
inhibition of autophagy abolishes the protective effects of
IPC in all the three organs, suggesting that autophagy may
be a common adaptive mechanism that is essential for the
resistance of preconditioned tissues to subsequent ischemic
injury. In our experimental models, renal IPC-induced autop-
hagy suppressed tubular cell apoptosis but not necrosis,
resulting in a significant but incomplete renoprotection.
These findings are different from the inhibitory effects of IPC-
induced autophagy on both cell apoptosis and necrosis in the
heart and liver [9,10,15], suggesting that the extent of the
protection mediated by autophagy during IPC may depend
on the tissue or cell type and injury duration.
Another interesting characteristic of renal IPC-induced
autophagy is the unique subcellular localization of autophagic
vacuoles in proximal tubular cells. Immunohistochemical
staining showed that LC3B-positive granules accumulated
along the brush boarder of preconditioned proximal tubules
(Figure 2(c)). EM further confirmed that autophagic vacuoles
induced by renal IPC were mainly seen at the apical cyto-
plasm of proximal tubules underneath the brush boarder
(Figure 2(e), circled areas). We also observed a remarkable
decrease in the number of reabsorption vacuoles in this area
as compared to sham control (Figure S1). To our knowledge,
these observations have not been reported previously.
Normally the cytoplasm immediately beneath the brush bor-
der is well controlled for cell organelle distribution.
Reabsorption vacuoles (also called secondary lysosomes) con-
tained in this area are involved in reabsorption and degrada-
tion of small amounts of protein that have leaked through the
glomerular filter. The mechanisms that contribute to the
specific subcellular distribution of autophagic vacuoles during
renal IPC needs to be further investigated. One possibility is
that, upon induction in IPC, autophagy mainly involves the
fusion of autophagosomes with reabsorption vacuoles or sec-
ondary lysosomes in IPC.
Unlike the observations in the heart and brain [9,11], in our
experiment models, IPC did not change the induction of general
autophagy during prolonged ischemia either in kidneys (Figure
S2) or in renal tubular cells (Figure S8). However, renal IPC
significantly enhanced selective mitophagy under these condi-
tions. We first used the mito-QC transgenic mouse model to
monitor mitophagy in vivo [34]. These mice carry a tandem
mitochondria-targeting fluorescence probe, mCherry-GFP-FIS
1, and the differential pH sensitivities between mCherry and
GFP allow us to measure the delivery of mitochondria to lyso-
somes to form mitolysosomes in the kidney. Interestingly, in
sham control mice, mitophagy occurred at a high basal level in
some cortical proximal tubules, with mitolysosomes positioned
predominantly at the apical side of proximal tubules toward the
lumen (Figure 5(b) and S5(b)). It is unclear what causes this
polarized distribution. However, given the consideration that the
apical side of renal proximal tubules are enriched for a large
number of ATP-dependent transporters for both excretion and
reabsorption, it is not surprising that a high rate of constant
mitochondrial turnover occurs in this area. In contrast to some
highly mitophagic proximal tubules in renal cortex, the proximal
tubules in S3 segment at the outer medulla showed minimal
mitochondrial turnover under basal condition and the occur-
rence of mitophagy in glomeruli was rare as well (Figure S5).
Mitophagy was significantly induced in proximal tubules follow-
ing renal IRI, and more importantly, renal IPC further enhanced
the intensity of mitolysosome formation in renal IRI (Figure 5(b,
c)). These in vivo results were further verified in cultured prox-
imal tubular cells by a comprehensive analysis of mitophagy
dynamics at different stages. In the cells subjected to ATP-
depletion stress, sIPC promoted the colocalization of mitochon-
dria with autophagosomes (initiation) (Figure S9), enhanced the
fusion of mitophagosomes with lysosomes to form mitolyso-
somes (progression) (Figure S10), and increased the degradation
of mitochondrial mass (clearance) (Figure S11). These results
demonstrate, unequivocally, that renal IPC enhances mitophagy
in proximal tubular cells during renal IRI. Moreover, IPC-
induced clearance of damaged mitochondria suppressed mito-
chondrial depolarization, improved ATP production and also
reduced ROS generation (Figure 8), further suggesting an
important role of IPC-mediated mitophagy in mitochondrial
quality control and IPC renoprotection. In support of our find-
ings, previous studies show that IPC in kidneys increases the
percentage of functionally active mitochondria, prevents nitric
oxide synthesis, and reduces the severity of kidney dysfunction
[40]. Moreover, IPC protection is significantly less in aged ani-
mals, which is associated with impaired autophagy/mitophagy
and the accumulation of dysfunctional mitochondria [41].
The upstream signaling involved in mitophagy induction
by renal IPC has yet to be determined. In IPC-mediated
cardioprotection, mitophagy mediated by PRKN and
SQSTM1 is suggested to eliminate damaged mitochondria
[21]. In our study, activation of PINK1, an important mito-
phagy mediator that recruits PRKN to damaged mitochon-
dria, was also seen in kidneys following renal IPC and IRI
(Figure 5(a)), which raises the possibility that PINK1-PRKN
signaling pathway may also regulate mitophagy induced by
renal IPC. Indeed, in cultured proximal tubular cells, both
PINK1 and PRKN were induced and accumulated in mito-
chondria in response to IPC and prolonged CCCP treatment
(Figure 9(a), PINK1, PRKN). Knockdown of Pink1 in these
cells remarkably abolished mitolysosome formation and mito-
phagy flux (Figure 9(c,d)), suggesting a regulatory role of the
PINK1-PRKN pathway in in vitro IPC-mediated mitophagy.
In addition, HIF1A (hypoxia inducible factor 1 subunit alpha)
is an important mediator of IPC in the kidney. Under hypoxia
conditions, both BNIP3 and BNIP3L/NIX are activated by
HIF1A [5]. In cultured MEF cells, induction of mitophagy
during hypoxia is regulated by HIF1A-dependent activation of
BNIP3 [42]. The role of BNIP3L/NIX in inducing general
autophagy and in priming damaged mitochondria for selec-
tive autophagic recognition has also been shown in CCCP-
induced mitochondrial depolarization in MEF cells [43].
Consistently in our study, an accumulation of BNIP3L/NIX
in mitochondria was also detected in cultured renal proximal
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tubular cells under both IPC and prolonged CCCP treatment
conditions (Figure 9(a), BNIP3L/NIX). Whether HIF1A-BNIP
3 or BNIP3L/NIX pathway contribute to mitophagy induction
by renal IPC during renal IRI needs to be elucidated.
Moreover, in our in vivo models, both LC3B immunohisto-
chemical staining and EM revealed a unique subcellular dis-
tribution of autophagic vacuoles in preconditioned proximal
tubules, which also happened to be at the apical side where
mitophagy was induced during subsequent renal IRI (Figure 2
(c,e)). Whether they are functionally connected (for instance,
autophagy induced during preconditioning phase may acti-
vate certain signaling to facilitate mitophagy during subse-
quent injury phase) is worth further investigations.
It remains unclear as to how general autophagy is activated
by renal IPC. Earlier studies in the heart show that IPC
enhances the expression of a pro-survival protein, BAG1
(BCL2-associated athanogene 1), which interacts with LC3
and induces autophagy for cardioprotection [9,44]. A recent
study further suggests that during cardiac IPC autophagy is
induced via epigenetic repression of Mtor (mechanistic target
of rapamycin kinase) by histone H3K9 dimethylation [45]. In
the liver, induction of autophagy during IPC is associated with
other stress adaptive signaling such as HMOX1 (heme oxyge-
nase 1) and nitric oxide [15,16]. Furthermore, endoplasmic
reticulum (ER) stress, through a chaperon protein HSPA5/
GRP78 (heat shock protein 5), activates autophagy in neural
cells during IPC [46]. Autophagy induced by cerebral IPC
reduces excessive ER stress during fetal ischemia and protects
neurons from ER stress-induced apoptosis [12,13]. These stu-
dies suggest inter-regulations between ER stress and autophagy
and the significance to IPC-mediated neuroprotection.
Cerebral IPC also induces autophagy via AMP-activated pro-
tein kinase (AMPK) and protects against ischemic stroke in rats
[14]. Despite these findings, the regulatory mechanisms under-
lying the activation of autophagy by renal IPC need to be
elucidated.
In conclusion, this study has demonstrated compelling
evidence for a role of autophagy in the protective effect of
IPC in kidneys. Particularly, mitophagy is specifically
enhanced by IPC during subsequent injury, resulting in the
removal of damaged mitochondria, improvement of mito-
chondrial function, reduction of ROS, and increase of cell
survival. As a prominent mechanism of intrinsic adaption,
IPC has gained continued attention and interest in both
basic science research and clinical application. However, the
translation of IPC to beneficial treatment for patients has been
limited. A better understanding of the mechanisms by which
IPC affords protection in various organs may facilitate the
discovery of new therapeutic targets for clinical use.
Materials and methods
Cell lines, antibodies and reagents
The immortalized RPTC cell line was originally obtained from
Dr. Ulrich Hopfer (Case Western Reserve University) and
maintained in DMEM/F-12 medium supplemented with 10%
fetal bovine serum and growth factors [47]. The retrovirus
packaging cell line (293-Phoenix) was provided by Drs.
Xiongjie Jin and Nahid F. Mivechi (Augusta University). The
cells were cultured in DMEM medium with 10% fetal bovine
serum. Primary antibodies: anti-LC3B (NB100-2220), anti-
PINK1 (BC100-494) and anti-FUNDC1 (NBP1-81063) were
from Novus Biologicals; anti-SQSTM1 (ab56416), anti-IMMT
/MIC60 (ab110329), anti-COX4I1 (ab153709) and anti-PPIB
(ab16045) were from Abcam; anti-TOMM20 (sc-11415), anti-
PINK1 (sc-517353), anti-PRKN (sc-133167), anti-BNIP3L/NIX
(sc-166332) and anti-HSPD1 (sc-13966) were from Santa Cruz
Biotechnology; anti-CASP3 (9665) and anti-cleaved CASP3
(9664) were from Cell Signaling Technology; anti DNM1L
(BD Biosciences, 611113); anti-ACTB (Sigma-Aldrich,
A5316). Secondary antibodies for immunoblot analysis were
from Jackson ImmunoResearch Laboratories. CCCP (C2759),
chloroquine (C6628) and 3-methyladenine (M9281) were from
Sigma-Aldrich. BECN1 peptide (Tat-BECN1, sequence:
YGRKKRRQRRRGGTNVFNATFEIWHDGEFGT) and its
control peptide (Tat-scrambled, sequence: YGRKK
RRQRRRGGVGNDFFINHETTGFATEW) were synthesized
by GenScript.
In vitro model of sIPC and renal IRI in RPTC cells and
examination of apoptosis
RPTC cells were plated in 35-mm dishes at a density of
1.0 × 106 cells/dish to reach ~95% confluence by next day.
To induce in vitro sIPC, cells were incubated with 20 μM
CCCP in regular Ca2+ Krebs-Ringer buffer (in mM: 115
NaCl, 1 KH2PO4, 4 KCl, 1 MgSO4, 1.25 CaCl2, 25
NaHCO3, pH 7.4) for 30 min followed by 40 min of recov-
ery in full culture medium. To mimic in vivo renal IRI, cells
were treated with 20 μM CCCP in regular Ca2+ Krebs-
Ringer buffer for 3 h followed by 2 h of recovery in full
culture medium. To test the effects of autophagy inhibitors,
RPTC cells were pretreated with 20 μM chloroquine or
10 mM 3-methyladenine for 1 h and the inhibitors were
added back into the cells during 2-h recovery from pro-
longed CCCP treatment. Apoptosis was examined by mor-
phology and caspase activation. Morphologically, cells were
stained with 10 μg/ml Hoechst 33342 (Molecular Probes,
H1399) to examine cellular and nuclear morphology by
phase contrast and fluorescence microscopy, respectively.
Cells with typically apoptotic characterizations were
counted to estimate apoptosis percentage. To measure cas-
pase activation, whole cell lysates were collected for immu-
noblot analysis of cleaved CASP3.
Animals
C57BL/6 mice were originally purchased from Jackson
Laboratory. The PT-atg7 KO mouse model was generated
and characterized in our lab [23]. The autophagy reporter
mouse model, which is transgenic of a tandem RFP-GFP-
LC3 fusion gene under the control of CAG promoter
(CAGp-RFP-GFP-LC3 mice), was established recently
[28]. The mitophagy reporter mouse model, mito-QC
that carries a tandem mCherry-GFP tag fused with mito-
chondrial outer membrane protein FIS1, was generated
lately [34]. Male mice 8- to 10-wk old were used for
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experiments. Mice were housed in a pathogen-free animal
facility of Charlie Norwood VA Medical Center under
a 12–12-h light-dark pattern with free access to food and
water. All animal experiments were conducted in accor-
dance with a protocol approved by the Institutional
Animal Care and Use Committee of Charlie Norwood
VA Medical Center.
Experimental models of renal IPC and renal IRI in mice
Before ischemia surgery, mice were anesthetized with pen-
tobarbital (50 mg/kg, i.p.) and kept on a Homeothermic
Blanket Control Unit (Harvard Apparatus, 507220F,
Holliston, MA) to monitor and maintain body temperature
at ~36.5ºC. Buprenorphine (0.05 mg/kg, i.p.) was used for
analgesia before and after surgery. To induce renal IPC,
renal pedicles were exposed for bilateral clamping to induce
15-min ischemia. The clamps were then released for reper-
fusion for 1 h. Mice were then subjected to 27-min bilateral
renal ischemia followed by reperfusion for up to 48 h to
induce renal IRI as described in our previous work [22,36].
During surgery additional anesthesia and analgesia were
given based on response to tail pinch. In some experiments,
mice were subjected to renal IPC only without subsequent
renal IRI and kidneys were collected 1 h after precondition-
ing. Sham control mice underwent the same operation with-
out renal pedicle clamping. To test the effects of autophagy
inhibitors, C57BL/6 mice were pretreated with either chlor-
oquine (60 mg/kg, i.p.) or 3-methyladenine (30 mg/kg, i.p.)
1 d and 1 h before surgery and continuously subjected to
the inhibitors daily throughout IPC and renal IRI duration.
To determine the effects of autophagy-inducing peptide,
C57BL/6 mice were given Tat-BECN1 or Tat-Scramble
(20 mg/kg, i.p.) 4 h before 27-min renal ischemia surgery.
Mice were sacrificed 48 h after renal IRI for histological and
biochemical analyses.
Examination of general autophagy in kidneys and in cells
1. Autophagy in RPTC cells and in kidney tissues was exam-
ined by immunoblot analysis of LC3B and SQSTM1 as
described recently [22,23,30]. In some experiments, LC3B-II
turnover assay was performed to monitor autophagic flux by
comparing the amount of LC3B-II in the absence vs presence
of chloroquine.
2. A polymer-based immunohistochemical staining of
LC3B was also used to determine autophagosome formation
in proximal tubules as described recently [30]. After perfused
fixation with 4% paraformaldehyde, mice were sacrificed and
kidneys were post-fixed in the same fixative overnight and
routinely paraffin-embedded. Tissue sections (4 μm) were
deparaffinized and incubated with 1 mM EDTA, 0.05%
Tween 20 (Fisher Scientific, BP337-500), pH 8.0 at 95–100°C
for antigen retrieval. After incubated with 3% H2O2 and with
a blocking buffer (2% bovine serum albumin [Sigma-Aldrich,
A9647], 0.2% milk, 2% normal goat serum [Jackson
ImmunoResearch Laboratories, 005–000-121], 0.8% Triton
X-100 [Sigma-Aldrich, T9284]), the slides were exposed to
1:500–1000 anti-LC3B at 4°C overnight and incubated with
Dako EnVision+ System horse radish peroxidase-labelled
polymer goat anti-rabbit secondary antibody (Dako North
America, K4002) for 30 min at room temperature. Signals
were visualized with a DAB Kit (Vector Laboratories, SK-
4100). For quantification, 10 to 20 fields (400×) were ran-
domly selected from each slide and the amount of LC3B dots
per proximal tubule was evaluated using ImageJ (National
Institutes of Health).
3. Examination of autophagic vacuoles in renal tissues by
EM was described in our recent work [22,48]. Briefly, after
treatment mice were sacrificed and immediately perfused
with 10 ml (10 units/ml) heparin, followed by 50 ml fixative
(100 mM sodium cacodylate, 2 mM CaCl2, 4 mM MgSO4, 4%
paraformaldehyde, 2.5% glutaraldehyde). Kidneys were har-
vested and post-fixed in the same fixative. An approximate
1 mm3 of tissue cube was collected from each kidney, including
a portion of renal cortex and outer medulla for standard EM
processing. The structures of autophagic vacuoles in proximal
tubular cells were revealed at high magnification (10,000×).
4. Autophagy dynamics was analyzed in RPTC cells expres-
sing mRFP-GFP-LC3 and in CAGp-RFP-GFP-LC3 transgenic
mice as described recently [30]. RPTC cells were transiently
transfected with mRFP-GFP-LC3 (ptfLC3; Addgene, 21074;
deposited by Dr. Tamotsu Yoshimuri) [29]. After treatment
cells were briefly fixed with 4% paraformaldehyde and
mounted with Prolong Diamond antifade reagent (Molecular
Probes, P36962) for fluorescence microscopy (Zeiss 780
upright confocal microscope, Carl Zeiss USA, Thornwood,
NY). For quantitative analysis, approximately 100 transfected
cells from 10 to 20 random fields (630×) were analyzed in
each condition. The numbers of yellow (colocalizing GFP-
LC3 with RFP-LC3) puncta per cell and total red (RFP-LC3)
puncta per cell were counted separately using ImageJ. The
number of autophagosomes was indicated by yellow puncta
and the number of autolysosomes was obtained by subtracting
yellow puncta from total red puncta. The number of auto-
lysosomes was further divided by the total number of RFP-LC
3 puncta to indicate the autophagic flux rate. For in vivo
experiments, after treatment CAGp-RFP-GFP-LC3 mice
were perfused with 4% paraformaldehyde. Kidneys were
further fixed overnight with the same fixative, balanced with
30% sucrose (Fisher Scientific, S5-500), and embedded in
Tissue-Tek® O.C.T. compound (Sakura Finetek USA, 4583)
for cryo-section (5 μm) and confocal microscopy. For each
section, 8 to 10 fields (630×) were selected randomly and
quantitative analysis was performed by the method described
above in RPTC cells.
Analysis of mitophagy in kidneys of mito-QC mice
Mito-QC is a newly established transgenic mouse model that
expresses a tandem mCherry-GFP tag fused to the mitochon-
drial outer membrane protein FIS1 [34]. As described above,
based on the differential sensitivities of mCherry and GFP to
the acidic lysosomal environment, this reporter mouse model
can accurately measure the delivery of mitophagosomes to
lysosomes and mitophagy flux in multiple organs including
the heart, brain, liver, spleen, skeletal muscles, and kidney
[34]. For our in vivo experiments, following renal IRI mito-
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QC mice were perfused with 4% paraformaldehyde. Kidneys
were further fixed overnight with the same fixative, balanced
with 30% sucrose, and embedded in Tissue-Tek® O.C.
T. compound for cryo-section (5 μm) and confocal micro-
scopy. For each section, 8 to 10 fields (400×) from renal cortex
and outer stripe of outer medulla were selected randomly and
the number of mCherry-only puncta (mitolysosomes) per
400× field (glomeruli excluded) was counted for quantifica-
tion using ImageJ.
Assessment of mitophagy in RPTC cells
A variety of complementary methods were used to monitor
mitophagy in RPTC cells at different stages:
(1) The initiation of mitophagy was determined by the
colocalization of mitochondria and autophagosomes.
RPTC cells were transiently transfected with GFP-LC3
(generously provided by Dr. Tamotsu Yoshimuri) [49].
Twenty-four h after transfection, cells were incubated
with 50 nM MitoTracker Red CMXRos (Molecular
Probes, M7512) in full culture medium for 30 min.
Following CCCP treatment in the presence of chloro-
quine, cells were briefly fixed in 4% paraformaldehyde
and mounted with Prolong Diamond antifade reagent
for confocal fluorescence microscopy. For quantifica-
tion, approximately 50 transfected cells from 8 to 10
random fields (630×) were analyzed in each condition.
The numbers of total GFP-LC3 puncta per cell (autop-
hagosomes) and colocalizing GFP-LC3 puncta per cell
(mitophagosomes) were counted separately using
ImageJ. The percentage of colocalizing GFP-LC3
puncta in total GFP-LC3 puncta was also calculated. It
is noteworthy that MitoTracker Red CMXRos carries
a thiol-reactive chloromethyl group that covalently
binds to the reduced thiols present in mitochondrial
matrix protein. For this reason, this dye can remain in
the mitochondria regardless of altered mitochondrial
function or mitochondrial membrane potential after
CCCP treatment and is also retained after fixation.
(2) The progression of mitophagy was determined by the
delivery of mitophagosomes to lysosomes. RPTC cells
were transiently transfected with COX8-EGFP-
mCherry (Addgene, 78520; deposited by Dr. David
Chan) for 24 h [37]. After CCCP treatment, cells were
briefly fixed in 4% paraformaldehyde and mounted
with Prolong Diamond antifade reagent for confocal
fluorescence microscopy. For quantification, approxi-
mately 80 to 100 transfected cells from 10 to 20
random fields (630×) were analyzed in each condition
and the number of mCherry-only puncta (mitolyso-
somes) per cell was counted using ImageJ.
(3) The clearance of mitochondria was determined by the
loss of mitochondrial mass. RPTC cells were incu-
bated with 50 nM MitoTracker Red CMXRos in full
culture medium for 30 min. Following CCCP treat-
ment cells were briefly fixed in 4% paraformaldehyde
and mounted with Prolong Diamond antifade reagent
for confocal fluorescence microscopy. To verify the
role of autophagy in mediating mitochondrial degra-
dation, chloroquine was used to block autolysosomal
acidification. For quantification, 15 to 20 fields
(630×) were randomly selected in each condition
and the intensity and area of MitoTracker Red stain-
ing was analyzed using ImageJ.
Assessment of mitochondrial membrane potential, ATP
production and ROS generation in RPTC cells
1. Mitochondrial membrane potential was examined in live cells
by the mitochondrial membrane potential sensitive dye JC-1.
RPTC cells were incubated with 1 µg/ml JC-1 (Molecular Probes,
T3168) in full culture medium for 1 h. After treatment, live cells
were directly examined by fluorescence microscopy (Zeiss 780
inverted confocal microscope, Carl Zeiss USA, Thornwood,
NY). For quantitative analysis, 8 to 10 fields (200×) were ran-
domly selected in each condition. The shift of JC-1 fluorescence
from red to green was measured and the ratio of green to red
fluorescence was analyzed using ImageJ.
2. ATP production was measured by a luciferin-luciferase
bioluminescence assay. After treatment RPTC cells were
extracted with 1x Reporter lysis buffer (Promega, E397A).
The cells were collected and then subjected to a single freeze-
thaw cycle (freeze at −80ºC for 5 min and thaw at room
temperature for 10 to 15 min) to ensure complete lysis. The
cell lysates were vortexed for 10 to 15 s and then centrifuged
at 12,000 g for 15 s at room temperature. The supernatants
were collected for ATP measurement using an ATP determi-
nation kit (Molecular Probes, A22066) as described by the
manufacturer. For each measurement, a standard curve was
constructed using ATP standard solutions. The amount of
ATP was calculated from the standard curve and normalized
with protein concentration (nM ATP/µg protein).
3. ROS generation was also measured to monitor mito-
chondrial function. Following CCCP treatment, RPTC cells
were incubated with 5 μM CellROX Deep Red reagent
(Molecular Probes, C10422) for 30 min. After brief fixation
in 4% paraformaldehyde, cells were mounted with Prolong
Diamond antifade reagent and ROS generation was visualized
by fluorescence microscopy.
Mitochondrial fractionation
After treatment RPTC cells were scraped and harvested with
homogenization buffer (10 mM HEPES-NaOH, pH 7.5,
220 mMmannitol, 70 mM sucrose) on ice. The cells were homo-
genized with 10 strokes using a syringe with 27-gauge needle and
centrifuged at 500 g for 5 min at 4ºC. The supernatants were
collected and further centrifuged at 8,000 g for 5 min at 4ºC. The
pellets containing crude mitochondria were washed with homo-
genization buffer and dissolved in 2% SDS buffer described below
for immunoblot analysis of various mitophagy-related proteins.
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Generation of stable RPTC cells by retroviral Pink1
shRNA infection
Pink1 rat shRNA (TR705269A, B, C, D) and its negative
control plasmids were purchased from OriGene
Technologies. 293-Phoenix cells were transiently transfected
with Pink1 shRNA and its negative control constructs using
Lipofectamine 2000 (Life Technologies, 11668). Forty-eight
h after transfection, the culture media containing a high titer
of viruses were collected and filtered to remove cell debris. To
establish stable cells, RPTC cells were seeded in 35-mm dishes
at a density of 0.5 × 106 cells/dish to reach ~50% confluence
by next day. The viral stocks and 2 µg/ml polybene (Santa
Cruz Biotechnology, sc-134220) were added into RPTC cul-
ture medium for infection. Forty-eight h after infection, the
cells were selected with 2.5 µg/ml puromycin (TaKaRa Bio
USA, 631305) for 10 d and then collected to examine the
efficiency of gene silencing by immunoblot analysis of PINK1.
Renal function, histology and TUNEL assay
Renal function was determined by BUN and serum creatinine
using commercial kits (Stanbio Laboratory, 0580 and 0420).
In brief, blood samples were collected for coagulation and
centrifugation at room temperature to collect serum. For
BUN, the reaction was conducted at 100°C for 12 min and
the absorbance at 520 nm was recorded by the end of reac-
tion. For serum creatinine, samples were added to a pre-
warmed (37°C) reaction mixture and the absorbance at
510 nm was monitored kinetically at 20 and 80 s of reaction.
BUN and creatinine levels (mg/dl) were then calculated based
on standard curves. Kidney tissues were fixed with 4% paraf-
ormaldehyde, embedded in paraffin, and sectioned at 4 μm.
H-E staining was performed using standard procedures. As
described before [22,23], renal tubules with the following
histopathological changes were considered injured: loss of
brush border, tubular dilation and disruption, cast formation,
cell lysis and with sloughed debris in tubular lumen. Tissue
damage was examined in a blind manner and scored by the
percentage of damaged tubules: 0, no damage; 1, <25%; 2,
25–50%; 3, 51–75%; 4, >75%. Apoptotic cells were identified
by TUNEL assay using an in situ cell death detection kit
(Roche Applied Science, 12156792910) as described pre-
viously [22,23]. Briefly, tissue sections were deparaffinized
and permeabilized with 0.1 M sodium citrate, pH 6.0 at 65°
C for 30 min. The sections were then incubated with
a TUNEL reaction mixture for 1 h at 37ºC in a humidified,
dark chamber. Positive nuclear staining was detected by fluor-
escence microscopy. For quantification, 10 to 20 fields (200×)
were randomly selected from each tissue section and the
amount of TUNEL-positive cells per mm2 tissue was
evaluated.
Immunoblot analysis
RPTC cells and kidney tissues from cortex and outer
medulla were lysed in 2% SDS buffer (62.5 mM Tris-HCl,
pH 6.8, 2% SDS, 10% glycerol) containing protease inhibitor
cocktail (Sigma-Aldrich, P8340) and Benzonase nuclease
(EMD Millipore, 70746). Protein concentration was deter-
mined by Pierce BCA protein assay kit (Thermo Scientific,
23225). Equal amounts (10 to 20 μg for cell lysate, 50 to
100 μg for tissue lysate) of protein were loaded in each lane
for electrophoresis and immunoblot analysis using standard
methods.
Statistics
Qualitative data including immunoblots and images are repre-
sentatives of at least 3 experiments. Quantitative data were
expressed as means ± SD (standard deviation). Statistical
analysis was conducted using the GraphPad Prism software.
Statistical differences in multiple groups were determined by
multiple comparisons with ANOVA followed by Tukey post
hoc tests. Statistical differences between 2 groups were deter-
mined by 2-tailed unpaired or paired Student t-test. P < 0.05
was considered significantly different.
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